Actively Recruiting
Evaluating Proton Therapy for Partial Breast Irradiation in Women with Early Stage Breast Cancer A Phase II Study to Assess Treatment Effects and Safety
Led by Proton Collaborative Group · Updated on 2026-09-29
132
Participants Needed
9
Research Sites
417 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of proton radiation therapy on women with early stage breast cancer, aiming to see if it offers benefits compared to existing treatments. The study focuses on whether targeting only the tumor region with proton therapy can reduce side effects and improve convenience over whole breast radiation. This phase II trial addresses gaps in current knowledge about the safety and effectiveness of partial breast irradiation using protons. Participants receive proton radiotherapy delivered as 4.0 Gy RBE doses over 10 sessions, totaling 40 Gy RBE aimed at the area around the tumor. This treatment approach avoids exposing the whole breast to radiation, potentially lowering damage to normal tissue. The study evaluates how feasible and safe this proton therapy method is for women who have undergone lumpectomy for early stage breast cancer. Women in the study will be monitored regularly for cancer recurrence at the original tumor site and any side effects from treatment. Researchers will assess quality of life and survival rates over a period of up to three years, with evaluations about every six months. The main outcome is whether the cancer returns in the treated breast region, while secondary outcomes include treatment toxicity and overall survival, ensuring thorough long-term follow-up.
CONDITIONS
Brief Title
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here